advertisement

WGA Rescources

European Journal of Pharmaceutics and Biopharmaceutics 10

Showing records 1 to 10 | Display all abstracts in European Journal of Pharmaceutics and Biopharmaceutics

61390 Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy
Hsu KH
European Journal of Pharmaceutics and Biopharmaceutics 2015; 94: 312-321
61143 New prostaglandin analog formulation for glaucoma treatment containing cyclodextrins for improved stability, solubility and ocular tolerance
Rodriguez-Aller M
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 203-214
61145 The aqueous humor outflow pathways in glaucoma: A unifying concept of disease mechanisms and causative treatment
Braunger BM; Fuchshofer R
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 173-181
61390 Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy
Carbia BE
European Journal of Pharmaceutics and Biopharmaceutics 2015; 94: 312-321
61143 New prostaglandin analog formulation for glaucoma treatment containing cyclodextrins for improved stability, solubility and ocular tolerance
Guinchard S; Guillarme D
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 203-214
61390 Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy
Plummer C
European Journal of Pharmaceutics and Biopharmaceutics 2015; 94: 312-321
61145 The aqueous humor outflow pathways in glaucoma: A unifying concept of disease mechanisms and causative treatment
Tamm ER
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 173-181
61143 New prostaglandin analog formulation for glaucoma treatment containing cyclodextrins for improved stability, solubility and ocular tolerance
Pupier M
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 203-214
61390 Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy
Chauhan A
European Journal of Pharmaceutics and Biopharmaceutics 2015; 94: 312-321
61143 New prostaglandin analog formulation for glaucoma treatment containing cyclodextrins for improved stability, solubility and ocular tolerance
Jeannerat D; Rivara-Minten E; Veuthey JL; Gurny R
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 203-214

Issue 17-1

Change Issue


advertisement

Oculus